Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Twist Bioscience Fiscal Q4 Revenues More Than Double

Twist Bioscience Fiscal Q4 Revenues More Than Double

Nov 23, 2020
|
staff reporter

NEW YORK – Twist Bioscience reported on Monday morning that revenues for its fiscal fourth quarter 2020 more than doubled year over year.

For the three months ended Sept. 30, 2020, the firm reported revenues of $32.4 million compared to $15.7 million in the year-ago period. It beat analysts' average revenue estimate of $22.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Worries About Increased Deadliness

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

Merck Stops SARS-CoV-2 Vaccine Development

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

PLOS Papers on Rare Venous Thromboembolism Variant, Vector Mosquito LncRNAs, More

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.

What's Popular?

In Business News

  1. Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates

  2. Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics

    Premium

  3. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  4. Lucira Health Files for $115M IPO

  5. People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.